Background and Purpose: This study was done to determine if reported declines in stroke mortality in the era before antihypertensive therapy are artifactual.
U nited States stroke mortality rates have been declining since at least 1900,1-3 but the reasons for this decline have remained obscure. Temporal changes in recognized stroke risk factors are insufficient to explain the decline. 45 Antihypertensive therapy first became available in the 1950s, and it was not until the 1960s and 1970s that large-scale public health campaigns were mounted to deal with the high prevalence of untreated hypertension in the United States. 2 The subsequent acceleration in the rate of decline of stroke mortality was initially attributed to the improved recognition and treatment of hypertension.6 However, more recent studies have questioned the magnitude of the contribution of antihypertensive treatment to the decline in stroke mortality4,5,7-9; in particular, Bonita and Beaglehole4 have suggested that hypertension can account for at most 25% of the decline in US stroke mortality from 1970 to 1980. Particularly in the era before antihypertensive therapy, it remains to be established whether the reported declines represent a real change in stroke mortality or were at least partly an artifact of changing diagnostic and reporting practices. If the reported decline in stroke mortality rates is real or if the trend can be corrected to adjust for identified bias, temporal changes in stroke mortality could be meaningfully compared with temporal changes in potential contributing factors, such as changing dietary patterns or the changing frequency of cigarette smoking.
This study evaluates the effect of various potential biases on the decline of stroke mortality in the era before antihypertensive therapy.
Materials and Methods
The number of deaths due to stroke and each stroke type by state, race, gender, and age were obtained from volumes of Mortality Statistics Table 1 . [10] [11] [12] [13] [14] [15] Population data by state, race, gender, and age were obtained from published tabulations of the population enumerated as of April 1 in the decennial censuses of 1900 through 1950.16-20 Population estimates for intercensal years were obtained by linear interpolation.
Age-adjusted mortality rates were computed by the direct method, that is, by applying the age-specific death Lanska and Mi Stroke Mortality Decline Before Antihypertensive Therapy 1383 Title name in ICD-5  ICD-5  ICD-4  ICD-3  ICD-2  ICD-1  Cerebral hemorrhage or effusion  83a  82a  74a  64  64  Cerebral embolism and thrombosis  83b  82b  74b During the period from 1940 through 1948, the DRA for the coterminous United States was complete, and there were no changes in coding systems or joint-cause selection rules. To evaluate whether some of the decline in stroke in this period was due to a shift in diagnosis or a shift in attribution of cause of death, age-adjusted mortality rates for stroke (ICD-5 rubric 83) and heart disease (ICD-5 rubrics 90 through 95) were calculated by state, race, gender, and year of death. The average rate of change of these rates was assessed by state for each race-gender group using linear regression. Analysis of residuals was used to identify violations of the assumptions of either linearity or homogeneity of variance.
Results
Age-adjusted stroke mortality rates declined by 41.7%, from 134.23/100 000 population per year in 1900 to 78.20/100 000 population per year in 1948 (Fig 1) . Declines occurred within the period of each revision of the ICD and were most precipitous during ICD-4 and ICD-5. Percentage declines for each ICD period are as follows: ICD-1, 6.5%; ICD-2, 3.6%; ICD-3, 2.9%; ICD-4, 16.3%; and ICD-5, 12.7%. Declines also occurred within the period of each revision of the jointcause selection rules.
The trends were not consistent for the various stroke types. Most stroke deaths from 1900 through 1948 were attributed to cerebral hemorrhage or effusion; rates for this diagnostic category actually increased from 1900 through 1916 and then declined. Almost all of the modest decline in overall stroke mortality rates in the first two decades of this century occurred as a result of a more precipitous decline in deaths from "hemiplegia and other paralysis of unspecified origin." Because the magnitude of the decline in this nonspecific category was greater than collective increases in other stroke categories, the decline resulted from either a true decline in deaths attributable to this category or, more likely, a shift to more specific conditions, including nonstroke categories. Although cerebral embolism and thrombosis represented only a small proportion of stroke diagnoses, rates for these conditions actually increased over the period.
With changes in ICD coding systems or joint-cause selection rules, there were generally minor discontinuities in trends, which did not explain the overall decline (Fig 1) . Two significant discontinuities occurred with sudden drops in rates upon adoption of ICD-3 in 1921 (a decrease of 6.6%) and application of the second . around 1925 and then declined (Fig 3) . After 1925 the declines were greatest in the originally high-rate areas, so that by 1933 the age-adjusted rates for the United States and for the death registration states of 1900, 1910, 1920 were almost identical (Fig 3) . Over the years 1917, 1925, and 1940, estimated ageadjusted mortality rates declined in parallel for stroke as the underlying or contributing cause of death, for stroke as the underlying cause of death, and for stroke as the only listed cause of death (Fig 4) . Reselection of the underlying cause of death for these years using uniform selection rules (1939 joint-cause manual) produced fairly wide ranges of recoded deaths and estimated rates for 1917 and 1925 (Table 2 and Fig 4) . For both of these years, the range of recoded stroke deaths and estimated rates included the original estimates. For the interval from 1925 through 1940, the recoded data support a decline in stroke mortality rates because even the lower end of the range of estimated rates in 1925 is greater than the rate for 1940.
Comparison of average annual rates of change for stroke and heart disease mortality rates by state did not support a shift in diagnosis to explain the divergent trends. Indeed, at a state level, the trends were not consistently divergent. For white men, rates increased for both conditions in 4 states, increased for heart disease and decreased for stroke in 30 (in 3, the decline in stroke was more than the increase in heart disease), and decreased for both conditions in 15. For white women, rates increased for both conditions in 3 states, increased for heart disease and decreased for stroke in 6 (in 4, the decline in stroke was more than the increase in heart disease), increased for stroke and decreased for heart disease in 3, and decreased for both conditions in 37. For nonwhite men, rates increased for both conditions in 9 states, increased for heart disease and decreased for stroke in 8 (in 4, the decline in stroke was more than the increase in heart disease), increased for stroke and decreased for heart disease in 8, and decreased for both conditions in 24. For nonwhite women, rates increased for both conditions in 7 states, increased for heart disease and decreased for stroke in 6 (in 2, the decline in stroke was more than the increase in heart disease), increased for stroke and decreased for heart disease in 11, and decreased for both conditions in 25.
Correlation analyses of state rates also did not support a shift in diagnosis to explain the divergent national trends in stroke and heart disease mortality rates. If a shift in diagnosis is the explanation for divergent trends, average annual rates of change for the two conditions should be negatively correlated. Instead, rates of change for stroke and heart disease rates are positively correlated for whites in the interval from 1940 through 1948: white men, r=.32, P=.02; white women, r=.39, P<.01. Rates of change are not significantly associated for nonwhites: nonwhite men, r-.14, P=NS (outlier Vermont excluded); nonwhite women, r=.04, P=NS (outlier Vermont excluded). Changes for nonwhites in Vermont were extreme in this interval and not consistent across gender: Rates decreased markedly for stroke and increased markedly for heart disease in men but increased markedly for both conditions in women.
Discussion
Some of the apparent decline in US stroke mortality rates before the advent of antihypertensive therapy is artifactual. Indeed, the entire reported decline in stroke mortality rates before 1925 can be explained by the combination of changes in disease classification systems, joint-cause selection rules, and geographic coverage of death certification. The decline after 1925 cannot be attributed to these factors and does not apparently result from a shift in diagnosis from stroke to heart disease. Other possible causes of artifactual mortality trends2829 -such as changes in recognition and reporting of individual diseases, changes in accuracy of reporting of age at death, and errors in the enumeration of the populations -either cannot be easily studied retrospectively or are unlikely to account for the generally steady and marked decline in stroke mortality rates over half a century.
Changes in the cause-of-death classification system produced only one marked discontinuity in stroke mortality trends during the interval from 1900 through 1948. The abrupt 6.6% decrease in stroke death rates with the introduction of ICD-3 in 1921 was of comparable magnitude to the net 8.7% decrease in ageadjusted stroke death rates over the previous 20 years. While stroke types were not accurately diagnosed in this period, changes in coding systems preferentially affected some stroke categories and were then reflected in overall stroke rates. The introduction of ICD-3 affected rates for cerebral hemorrhage as well as for cerebral embolism and thrombosis. ICD-2 rubric 64 ("cerebral hemorrhage, apoplexy") included several nonstroke terms that were transferred to nonstroke rubrics in ICD-3: "alcoholic edema of brain," "alcoholic wet brain," and "wet brain" were transferred to ICD-3 rubric 66 ("alcoholism"); "atheroma of brain" and "cerebral atheroma" were transferred to ICD-3 rubric 91b ("arteriosclerosis"); and "hemorrhagic pachymeningitis" was transferred to ICD-3 rubric 71a ("simple meningitis"). 10 12,13 Similarly, ICD-2 rubric 82 ("embolism and thrombosis") included noncerebral embolism and thrombosis, which were transferred to nonstroke rubrics in l2l3 Adoption of the other ICD revisions during the period from 1900 through 1948 -ICD-2, ICD-4, and ICD-5 -produced no marked breaks in continuity of stroke mortality trends, although considerable changes were made in the stroke list titles for ICD-2 and ICD-5.'0 '5 To measure the net effect of the ICD-5 revision, the US Bureau of the Census dually coded all reported deaths for the year 1940 using both ICD-5 and ICD-4.30 As anticipated from examination of stroke trends, the net effect of the ICD-5 revision was minimal: 119 753 stroke deaths were coded with ICD-5 compared with 120 306 coded with ICD-4, a net decrease of less than 0.5%. Changes for each stroke type were also small: -0.3% for cerebral hemorrhage, -2.4% for cerebral embolism and thrombosis, -0.7% for hemiplegia and other paralysis, and + 2.3% for cerebral softening.
From 1900 through 1948, changes also occurred in the rules for selection of the underlying cause of death from among all causes listed on the death certificate. The first revision of the International List incorporated a vague set of rules for joint-cause selection, which produced arbitrary and inconsistent coding.1" To improve the selection procedures, the Index of Joint Causes of Death25 was published in 1914. In the 1914 manual each individual term was given a "weight"; unfortunately, this manual did not include all combinations of joint causes of death that appeared on certificates, so registrars were still forced to make arbitrary selections of the underlying cause of death.26 A second edition, The Manual of Joint Causes of Death,26 was published in 1925. In the 1925 and later manuals, any term listed under a joint-cause subdivision has the same "weight" as all other terms included under that subdivision. 26.27,31 Further changes in assignment were made in the third edition in 1933,31 and very minor changes were made in the fourth edition in 1939. 27 A large break in continuity in stroke mortality trends -a decrease of 9.2% -occurred with institution of the new joint-cause selection rules in 1925, whereas the revisions of selection rules in 1914, 1933, and 1939 had little apparent effect on overall stroke rates. With the 1925 revision, the terms under ICD-3 rubric 74a ("cerebral hemorrhage") were given less weight in selection of the underlying cause than conditions frequently reported in combination with cerebral hemor-rhage, particularly diseases of the heart and chronic nephritis. 25, 26, 30 Reselection of the underlying cause of death from aggregate joint-cause tabulations for 1917, 1925, and 1940 using uniform selection rules produced wide ranges of recoded deaths and estimated rates for 1917 and 1925. Nevertheless, for the interval from 1925 through 1940, the recoded data support a decline in stroke mortality rates because even the lower end of the range of estimated rates in 1925 is greater than the estimated rate for 1940. In addition, estimated ageadjusted stroke mortality rates also declined from 1925 through 1940 for stroke listed as any cause of death and for stroke listed as the only cause of death.
Although changes in classification systems and jointcause selection rules contributed to the apparent decline in stroke mortality rates before the advent of antihypertensive therapy, the major discontinuities associated with these factors occurred before 1925. Other factors must be involved because stroke rates continued to decline from 1925 through 1948 and because declines in stroke mortality rates occurred within the period of each of the first five revisions of the ICD and within the period of each of the four editions of the joint-cause selection manual.
One additional important factor involved in the apparent decline was a changing geographic area for death registration. In the early twentieth century, national estimates of mortality rates were based on deaths in the DRA. Admission of states and cities to the DRA required at least 90% completeness of death registration, use It has been suggested that some decline in stroke mortality rates may be due to a shift in diagnosis from stroke to heart disease. 2, 6 Indeed, national mortality trends for stroke and heart disease were divergent before the 1960S2: Rates for heart disease increased, whereas rates for stroke declined. However, comparison of average annual rates of change for stroke and heart disease mortality rates by state from 1940 through 1948 did not support a shift in diagnosis to explain the divergent trends. Indeed, except for white men, trends were more often consistent than divergent for stroke and heart disease mortality rates. In addition, rates of change for stroke and heart disease mortality rates were positively correlated for white men and for white women and not associated for blacks; if a shift in diagnosis was responsible for the divergent national trends, average annual rates of change at a state level should have been negatively correlated, but they were not. An analysis by Moriyama and colleagues2 of changes in these conditions from 1949 through 1951 to 1959 through 1961 also failed to identify evidence to support a major shift in diagnoses from stroke to heart disease.
The causes for the decline in stroke mortality rates after 1925 are unknown, but the decline from this point cannot readily be attributed to artifacts. If the marked decline in stroke mortality rates from 1925 through 1948 is not artifactual, the decline in stroke mortality rates began decades before the decline in ischemic heart disease mortality rates233 -37 and decades before any known declines in the prevalence or severity of recognized stroke risk factors, including hypertension and cigarette smoking. [38] [39] [40] [41] [42] [43] [44] D J Lanska and X Mi Decline in US stroke mortality in the era before antihypertensive therapy.
